<?xml version="1.0" encoding="UTF-8"?>
<p id="para0003">Here, we present a retrospective review of candidaemias in adult patients (&gt;17 years) with PCR proven COVID-19 between 1
 <sup>st</sup> March 2020 - 31
 <sup>st</sup> May 2020 across six acute London hospitals. All yeasts isolated from blood cultures were identified by matrix assisted laser desorption/ionisation-time-of-flight (MALDI-TOF) mass spectroscopy (Bruker Daltonik GmbH, Bremen, Germany). Antifungal susceptibility testing was carried out using broth micro-dilution in accordance with EUCAST guidelines (
 <xref rid="bib0004" ref-type="bibr">4</xref>). An episode of candidaemia was defined as blood culture growth of any 
 <italic>Candida</italic> species.
</p>
